- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02958098
My Research Legacy Pilot Study
Study Overview
Status
Detailed Description
2,000 Participant My Research Legacy Pilot Study
Day 0 - Enroll online, complete AHA's Life's Simple 7™ Survey Prospective participants will enroll in the research initiative via the My Research Legacy website (MyResearchLegacy.org). They will go through an online process in which they will answer brief, pre-qualifying questions before consenting to participate in the study.
- Participants will attest to their age and US residence, and will provide a self-reported diagnosis of cardiovascular disease (myocardial infarction, atrial fibrillation, aortic dissection, systolic congestive heart failure/cardiomyopathy) and/or stroke.
- Eligible participants will read and sign an online consent form.
- Within the participant console, the participants will answer AHA's Life's Simple 7™ My Life Check v4.0 assessment.
- Participants will be asked during the consent process if they will consent to provide medical records relevant to their diagnosis.
- Day 90 Complete AHA's Life's Simple 7™ My Life Check v4.0 assessment; Start transmission from the Fitbit Charge 2.
- Online Survey and contact Day 180 after enrollment, participants will receive an email requesting that they visit the participant console to repeat AHA's Life's Simple 7™ My Life Check v4.0 survey. Participants also have the option of determining whether or not they want to be contacted for future studies.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > or = to 18 years but < 50 years.
History of one (or more) of the following:
- Myocardial infarction
- Stroke
- Aortic dissection
- Systolic heart failure/cardiomyopathy
- Atrial fibrillation
- Individuals of any age > or = 18 years who don't have above medical conditions but want to participate in the study.
- Access to a computer and/or cell phone with internet access.
Exclusion Criteria:
- Unwillingness to sign informed consent
- No access to a computer and/or cell phone with internet access.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Myocardial infarction
Individuals with myocardial infarction before age 50 years.
|
|
Stroke
Individuals with stroke before age 50 years
|
|
Aortic dissection
Individuals with aortic dissection before age 50 years
|
|
Systolic heart failure
Individuals with systolic heart failure/dilated cardiomyopathy before age 50 years.
|
|
Atrial fibrillation
Individuals with atrial fibrillation before age 50 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
study retention
Time Frame: 6 months
|
continues to engage with study after 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in answers to AHA's Life's Simple 7™ My Life Check v4.0
Time Frame: 6 months
|
answers to second and other surveys
|
6 months
|
|
Duration of time Fitbit Charge 2 used by participants
Time Frame: 6 months
|
recorded time
|
6 months
|
|
Change in Fitbit Charge 2 step count
Time Frame: 6 months
|
recorded steps
|
6 months
|
|
Percent of individuals that initiate but don't complete online process
Time Frame: 6 months
|
number that start but don't finish first surveys
|
6 months
|
|
Activity duration
Time Frame: 6 months
|
Daily, weekly, monthly activity from Fitbit Charge 2
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jane A Leopold, MD, American Heart Association
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Genetic Diseases, Inborn
- Arrhythmias, Cardiac
- Cardiomegaly
- Laminopathies
- Aneurysm
- Myocardial Infarction
- Infarction
- Heart Failure
- Atrial Fibrillation
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Aneurysm, Dissecting
- Heart Failure, Systolic
Other Study ID Numbers
- My Research Legacy Pilot Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Beijing Northland Biotech. Co., Ltd.Not yet recruitingAcute Myocardial Infarction (AMI) | Acute Myocardial Infarction of Anterior Wall | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction With ST Segment Elevation | Acute Myocardial Infarction of Left VentricleChina
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SAWithdrawn
-
Samsung Medical CenterThe Korean Society of CardiologyNot yet recruiting
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationCompletedST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionUnited States, Spain, Netherlands, Canada, Australia, Serbia, Egypt, Switzerland, Hungary, United Kingdom, France, Czechia, Nepal, North Macedonia
-
Harbin Medical UniversityNot yet recruitingNon-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)Acute Myocardial Infarction (AMI) | ST-Segment Elevation Myocardial Infarction(STEMI) | Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)China
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark